| ANOVA | Analysis of variance |
| Arg-1 | arginase-1 |
| bFGF BMDMs | Basic fibroblast growth factor Bone marrow-derived macrophages; |
| BrdU | bromodeoxyuridine |
| DMEM | Dulbecco’s Modified Eagle’s medium |
| DOX | doxorubicin |
| FasL | Fas ligand |
| G-CSF | Granulocyte-colony stimulating factor |
| GM-CSF | Granulocyte-macrophage-colony stimulating factor |
| HPLC | high-performance liquid chromatography |
| IC50 | Half maximal inhibitory concentration |
| IFN-γ | Interferon γ |
| IGF-II | Insulin growth factor II |
| IL-1α | Interleukin 1α |
| IL-1β | Interleukin 1β |
| IL-4 | Interleukin 4 |
| IL-6 | Interleukin 6 |
| IL-9 | Interleukin 9 |
| IL-10 | Interleukin 10 |
| IL-12 p40 | Interleukin 12 p40 |
| IL-12 p70 | Interleukin 12 p70 |
| IL-13 | Interleukin 13 |
| MDA | Malondialdehyde |
| MIG | Monokine induced by IFN-γ |
| M-CSF | Monocyte-colony stimulating factor |
| MCP-1 | Monocyte chemoattractant protein-1 |
| PF-4 | Platelet factor 4 |
| PLP | Prednisolone disodium phosphate |
| SD | Standard deviation |
| TAMs | tumor - associated macrophages |
| TBS | Tris-buffered saline |
| TIMP-1 | Tissue inhibitor of metalloproteinase 1 |
| TIMP-2 | Tissue inhibitor of metalloproteinase 2 |
| TME | Tumor microenvironment |
| TNF-α | Tumor necrosis factor α |
| TPO | Thrombopoietin |
| VEGF | Vascular endothelial growth factor |